Symbiox Investment & Trading Co Ltd / Fundamentals
Income statement
- Net revenue
€259.03K - Cost of goods sold
€163.50K - Gross profit
€95.54K - SG&A expenses
€11.70K - R&D expenses
€0.00 - EBITDA
€55.93K - D&A
€298.18 - EBIT
€71.45K - Interest expenses
€0.00 - EBT
€58.15K - Tax expenses
€12.66K - Net income
€45.49K
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€45.49K - Changes in working capital
€0.00 - Operating cash flow
€0.00 - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
€0.00 - Cash at end of period
€0.00 - Free cash flow
€0.00
Balance sheet
- Cash and cash equivalents
€0.00 - Cash and short-term investments
€1.09M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
-€1.09M - Total current assets
€0.00 - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€0.00 - Total assets
€0.00 - Accounts payable
€0.00 - Short-term debt
€0.00 - Other current liabilities
€0.00 - Total current liabilities
€0.00 - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
-€3.13M - Total non-current liabilities
-€3.13M - Total liabilities
-€3.13M - Common stock
€0.00 - Retained earnings
€0.00 - Other equity
€3.13M - Total equity
€3.13M - Total liabilities and shareholders' equity
€0.00
Company information
- Market capitalization
€854.49K - Employees
0 - Enterprise Value
€104.32M
Company ratios
- Gross margin
-
36.9% - EBITDA margin
-
21.6% - EBIT margin
-
27.6% - EBT margin
-
22.4% - Net margin
-
17.6% - ROE
-
1.5% - ROA
-
0.0% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
0.0% - Efficiency ratio
78.4% - Net sales per employee
-
€0.00 - Net income per employee
-
€0.00